Heliatek GmbH to Focus on the Integration of Glass and Solar Films

Heliatek GmbH, a global leader in manufacturing high-end Solar Films, has signed a joint development agreement with AGC Glass Europe, European branch of AGC (the world's largest producer of flat glass), already active in traditional BIPV.

The agreement is focused on researching and developing the integration of glass and Solar Films, targeting the delivery of integrated solutions for the glass envelope of buildings.

This will enable the entire glass façades of buildings, including windows, to become highly efficient, cost-effective, solar energy harvesters to reduce a building's carbon footprint combined with a discrete, aesthetically-pleasing, visual appearance.   

Heliatek's award-winning, Solar Films are ideally suited to this application because they can be opaque or semi-transparent in a variety of colors.  The films are ultra-light, ultra-thin and highly efficient under real world conditions, thanks to three unique features.  They harvest the sun's energy at peak efficiency for longer daytime periods than traditional solar technologies: from full sun down to a tenth of full sun, such as on a cloudy day.  In addition, they can operate efficiently in any orientation, even when not directly facing the sun and only receiving indirect or diffused light. Finally, their performance remains stable up to 80°C.

The key to Heliatek's success is the family of small organic molecules - oligomers - developed and synthesized at its own lab in Ulm, Germany. Heliatek is the only solar company in the world that uses the deposition of small organic molecules in a low temperature, roll-to-roll vacuum process. Its solar tandem cells are made of nanometers-thin layers of high purity and uniformity. This enables the company to literally engineer the cell architecture to systematically improve efficiency and lifespan. © Heliatek GmbH.

Thibaud Le Séguillon, CEO of Heliatek, explains: "Once developed, this will open up all vertical glass surfaces for PV.  They offer a much larger installation area than roof tops that are the focus of today's solar building installations, plus there are no additional installations costs unlike conventional PV panels."

Marc Van Den Neste, CTO of AGC Glass Europe, adds: "This agreement fits in perfectly with our strategy of providing affordable and environment-friendly glass solutions to our customers, the building industry and the community at large.  I am confident that this solution will open up new prospects for creativity and energy efficiency to architects and designers."

Alexander Valenzuela, VP Business at Heliatek, concludes: "Together, we understand and will meet the building industry requirements as well as the needs of the architects and end-users regarding reliability, life-expectancy and return-on-investment."  

About Heliatek

Heliatek, a global leader in high-end solar technology, was spun-off in 2006 from the Technical University of Dresden (IAPP) and the University of Ulm. It is the global technology leader in the field of organic photovoltaic (OPV) and manufactures solar films based on small molecules and has just recently set a new world record by achieving a cell efficiency of 12%. Heliatek maintains a total staff of 70 employees and specialists at its facilities in Dresden and Ulm, Germany. Investors in Heliatek include leading industrial and financial companies such as BASF, Bosch, RWE, Wellington Partners and eCapital.

About AGC Glass Europe

Based in Belgium, AGC Glass Europe produces, processes and distributes flat glass for the construction (external glazing and interior decorative glass), the automotive (original and replacement glass), and the solar sectors. It has over 100 sites throughout Europe, from Spain to Russia, and employs around 14,500 employees.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.